Primary Job Title Chief Executive Officer Primary Organization GT Biopharma
Gender Male
LinkedIn View on LinkedIn
Mr. Cataldo joined the Oxis International Board of Directors in July of 2014. From February 2011 to June 2013 Mr. Cataldo served as FOUNDER and Chairman/CEO of Genesis Biopharma, inc., now known as Lion Biotechnologies, Inc., (LBIO). Mr. Cataldo created the highly successful Lion/Genesis (LBIO) with the inclusion of assets acquired from
the National Cancer Institute for the treatment of stage four melanoma. Mr. Cataldo has extensive experience in the biotechnology sector having served as Chairman/CEO of several biotech companies including: MultiCell Technologies, Inc., Calypte Biomedical Corporation, and Senetek, PLC.
